secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001683168-24-008332
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals terminates exclusive supply agreement with EMC Pharma
----------------------------------------------------------------------------

- EMC Pharma failed to meet minimum purchase quantities; 30-day cure period expired.
- Termination effective November 21, 2024; no penalties incurred by Sonoma.
- Sonoma resumes direct U.S. sales of Microcyn-based products: Acuicyn, Celacyn, Epicyn, Lasercyn, Levicyn.
- Agreement had a five-year initial term; exclusive distribution rights now ended.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824008332/0001683168-24-008332-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824008332/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008332

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer